Dr. Bryan John Trottier Jr., MD

Dr. Trottier practices at M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview.

Dr. Trottier's NPI, 1659550309, was assigned on October 30, 2007. Dr. Trottier graduated from University Of Minnesota Medical School in 2007. Dr. Trottier's Minnesota license number on file is 52717.

Dr. Trottier's primary practice is M Health Fairview University of Minnesota Medical Center, at 2450 Riverside Avenue, Minneapolis, MN 55454 in Hennepin County. The practice phone is (612) 624-1765.

Dr. Trottier's primary practice is M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview. Dr. Trottier is also affiliated with M Health Fairview Southdale Hospital. The medical group on file is M Health Fairview Recovery Clinic. Dmand AI also links Dr. Trottier to 3 more hospitals, 5 group practices and clinics, 5 medical groups and 1 dialysis center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Trottier practices, 11 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Trottier's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Trottier has a license on file in Minnesota.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), lung cancer, lymphoma and multiple myeloma among the conditions Dr. Trottier treats.

CMS data shows 1,058 Medicare services from Dr. Trottier across 14 procedure codes in 2024, for 281 Medicare patients. Medicare paid $49,567 for them.

CMS counts 281 Medicare patients who saw Dr. Trottier in 2024. The largest group is 65 to 74, with 115 patients. 69% of them have high blood pressure, and 64% have high cholesterol. 14% are also on Medicaid. Their average risk score is 2.35, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Trottier's median patient age at 71, with 62% women.

In 2024, Dr. Trottier wrote 1,674 Medicare Part D claims for 266 patients. 68% of them were for generic drugs. CMS names the drug for 1,375 of them, across 38 drugs with 11 or more claims each, at $7,355,989 in total drug cost. In 2023, CMS named 1,246 claims across 39 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Trottier for performance year 2024, reported as part of a group. Dr. Trottier accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Trottier as offering telehealth.

Dmand AI links 6 papers to Dr. Trottier, published from 2014 to 2016. 2015 was the busiest year, with 2. The most frequent topics are Hematopoietic Stem Cell Transplantation, Myelodysplastic Syndromes and Transplantation Conditioning. Dr. Trottier has published most often in Biol Blood Marrow Transplant. Dr. Trottier's most frequent co-authors are Celalettin Ustun, MD, Nelli Bejanyan, MD and Daniel J. Weisdorf, MD.

CMS Open Payments shows 2 general payments to Dr. Trottier from 2 drug and device companies from 2017 to 2020. Education make up the largest share, 100% of the total. Millennium Pharmaceuticals, Inc. paid the most, $12.

Dr. Trottier graduated from University Of Minnesota Medical School in 2007.

Dr. Trottier is in network with 17 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.